Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2025-12-26 @ 11:13 PM
NCT ID:
NCT05668312
Eligibility Criteria:
Inclusion Criteria for TELE-pre and Con-O groups (also previous information are valid only for these groups):
* Scheduled unilateral total knee replacement surgery according to Fast-Track pathway;
* Preoperative criteria for home discharge;
* At least one person cohabitant;
* Familiarity with tablet/computer use and Internet access;
* Informed consent signature.
Inclusion Criteria for Con-Y group:
* Both sexes of any ethnicity;
* Age between 18 and 35 years;
* Scheduled Anterior Cruciate Ligament reconstruction surgery;
* Body Mass Index ≤ 30.
Exclusion Criteria for TELE-pre and Con-O groups:
* Scheduled surgery for knee revision arthroplasty;
* Lower limbs surgery in the previous 6 months;
* Lower limbs fractures in the previous 6 months;
* Congenital or post-traumatic knee morphologic alterations;
* Rehabilitation treatments in the previous 6 months focused on the interested knee functional recovery;
* Ongoing neurological or oncological diseases;
* HIV, HCV, HBV, TPHA infection;
* Cognitive impairment;
* Known local anaesthetics allergic reactions;
* Ongoing non-suspendable anticoagulant therapies;
* Known muscular diseases.
Exclusion Criteria for Con-Y group:
* Body Mass Index \> 30;
* Ongoing oncological diseases;
* Sampling area infection;
* HIV, HCV, HBV, TPHA infection;
* Known neuromuscular/muscular diseases;
* Ongoing non-suspendable anticoagulant therapies,
* Female subjects in pregnancy status or breastfeeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Maximum Age:
80 Years
Study:
NCT05668312
Study Brief:
Protocol Section:
NCT05668312